Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-22-013094
Filing Date
2022-05-19
Accepted
2022-05-19 17:09:22
Documents
1
Period of Report
2022-05-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 7489
  Complete submission text file 0001437749-22-013094.txt   9065
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address
Noseda Alessandro (Reporting) CIK: 0001777031 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15070 | Film No.: 22944076